Table 6.
Predictors associated with physical component score of health-related quality of life for PLWHIV
| Characteristic | β | SE | Z-value | P-value |
|---|---|---|---|---|
| Strategy practice effect | ||||
| Strategy 1 | – | – | – | – |
| Strategy 2 | − 2.753 | 1.617 | − 1.700 | 0.089 |
| Strategy 3 | − 0.357 | 1.611 | − 0.220 | 0.825 |
| Strategy 4 | 1.345 | 2.266 | 0.590 | 0.553 |
| Age (years) | ||||
| 16–18 | – | – | – | – |
| 18–30 | − 0.660 | 2.297 | − 0.290 | 0.774 |
| 30–45 | − 2.286 | 2.299 | − 0.990 | 0.320 |
| 45–60 | − 4.030 | 2.303 | − 1.750 | 0.080 |
| ≥ 60* | − 6.539 | 2.351 | − 2.780 | 0.005 |
| Race/ethnicity | ||||
| Han nationality | ||||
| Yi minority | 0.328 | 0.626 | 0.520 | 0.600 |
| Zhuang minority | 0.805 | 0.634 | 1.270 | 0.205 |
| Other minority ethnic group | 0.302 | 0.506 | 0.600 | 0.551 |
| Marital status | ||||
| Separated/Divorced/Unmarried | – | – | – | – |
| Married/Cohabitating | 0.593 | 0.362 | 1.640 | 0.102 |
| Education level | ||||
| < 9 years | – | – | – | – |
| ≥ 9 years | 0.686 | 0.380 | 1.810 | 0.071 |
| Occupation | ||||
| Workers | – | – | – | – |
| Public officers/Staff member* | 1.854 | 0.768 | 2.410 | 0.016 |
| Farmers | 1.002 | 0.616 | 1.630 | 0.104 |
| Migrant workers | 1.197 | 0.752 | 1.590 | 0.111 |
| Self-employed | 0.149 | 0.700 | 0.210 | 0.831 |
| Unemployed | − 0.144 | 0.745 | − 0.190 | 0.847 |
| Household income per year (CNY) | ||||
| < 5000 | – | – | – | – |
| 5000–10 000 | 0.470 | 0.440 | 1.070 | 0.285 |
| 10 000–50 000* | 0.997 | 0.464 | 2.150 | 0.032 |
| ≥ 50 000 | 1.625 | 1.096 | 1.480 | 0.138 |
| HIV status known by others | ||||
| No one knowing | – | – | – | – |
| Partially* | − 0.948 | 0.415 | − 2.29 | 0.022 |
| All* | − 2.376 | 0.680 | − 3.49 | 0.001 |
| No clear* | − 1.992 | 0.772 | − 2.58 | 0.010 |
| Initial infectious status | ||||
| HIV status | – | – | – | – |
| AIDS status | 0.162 | 0.398 | 0.410 | 0.684 |
| Transmission model | ||||
| Heterosexual transmission | – | – | – | – |
| Homosexual transmission | − 0.389 | 0.720 | − 0.540 | 0.589 |
| Intravenous drug use* | − 2.083 | 0.540 | − 3.860 | 0.001 |
| Mother-to-infant | − 3.974 | 2.117 | 1.880 | 0.060 |
| Unclear* | − 2.119 | 0.975 | − 2.170 | 0.030 |
| Duration of antiretroviral therapy | ||||
| ≤ 1 years | – | – | – | – |
| 1–2 years | − 0.296 | 0.720 | − 0.410 | 0.681 |
| 2–4 years | 0.720 | 0.606 | 1.190 | 0.235 |
| ≥ 4 years | − 0.244 | 0.533 | − 0.460 | 0.647 |
| Not yet | 1.472 | 1.597 | 0.920 | 0.357 |
| The most recent CD4 counts | ||||
| ≥ 500 cells/μl | – | – | – | – |
| 350–500 cells/μl | − 0.330 | 0.432 | − 0.760 | 0.445 |
| 200–350 cells/μl | 0.188 | 0.478 | 0.390 | 0.694 |
| < 200 cells/μl * | − 2.046 | 0.663 | − 3.090 | 0.002 |
| Unclear | − 0.081 | 2.286 | − 0.040 | 0.972 |
| Social support* | 0.086 | 0.026 | 3.340 | 0.001 |
| Anxiety* | − 0.496 | 0.070 | − 7.070 | 0.001 |
| Depression* | − 0.080 | 0.069 | − 2.980 | 0.003 |
*P < 0.05. PLWHIV people living with HIV. Strategy1: the strategy with good practice; Strategy 2: the strategy with traditional advantage practice; Strategy 3: the strategy with advanced practice; Strategy 4: the strategy with the general practice